Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study.

Papi, Alberto; Kostikas, Konstantinos; Wedzicha, Jadwiga A; Vogelmeier, Claus F; Roche, Nicolas; Shen, Steven; Banerji, Donald; Fogel, Robert; Patalano, Francesco; Chapman, Kenneth R

Papi, Alberto; Kostikas, Konstantinos; Wedzicha, Jadwiga A; Vogelmeier, Claus F; Roche, Nicolas; Shen, Steven; Banerji, Donald; Fogel, Robert; Patalano, Francesco; Chapman, Kenneth R.

Affiliation

Papi A; 1 University of Ferrara Ferrara, Italy.
Kostikas K; 2 Novartis Pharma AG Basel, Switzerland.
Wedzicha JA; 3 Imperial College London London, United Kingdom.
Vogelmeier CF; 4 Philipps-Universität Marburg Marburg, Germany.
Roche N; 5 University Paris Descartes Paris, France.
Shen S; 6 Novartis Pharmaceuticals Corporation East Hanover, New Jersey.
Banerji D; 6 Novartis Pharmaceuticals Corporation East Hanover, New Jersey.
Fogel R; 6 Novartis Pharmaceuticals Corporation East Hanover, New Jersey.
Patalano F; 2 Novartis Pharma AG Basel, Switzerland.
Chapman KR; 7 University Health Network Toronto, Ontario, Canada and.

Am J Respir Crit Care Med ; 197(9): 1223-1226, 2018 05 01.

Article in En | MEDLINE | ID: mdl-29099609

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Pulmonary Disease, Chronic Obstructive / Eosinophilia / Eosinophils Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2018 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google